Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Theelen WSME"'
Autor:
van der Wel JWT; Department of Thoracic Oncology, Netherlands Cancer Institute, The Netherlands., Jebbink M; Department of Thoracic Oncology, Netherlands Cancer Institute, The Netherlands., van den Broek D; Department of Laboratory Medicine, Netherlands Cancer Institute, The Netherlands., Steinbusch LC; Department of Thoracic Oncology, Netherlands Cancer Institute, The Netherlands; Department of Pulmonary Diseases, Leiden University Medical Center, The Netherlands., Theelen WSME; Department of Thoracic Oncology, Netherlands Cancer Institute, The Netherlands., Ruiter G; Department of Thoracic Oncology, Netherlands Cancer Institute, The Netherlands., Buikhuisen W; Department of Thoracic Oncology, Netherlands Cancer Institute, The Netherlands., Burgers JA; Department of Thoracic Oncology, Netherlands Cancer Institute, The Netherlands., Baas P; Department of Thoracic Oncology, Netherlands Cancer Institute, The Netherlands., Vermeulen M; Department of Biometrics, Netherlands Cancer Institute, The Netherlands., van der Noort V; Department of Biometrics, Netherlands Cancer Institute, The Netherlands., Hashemi SMS; Department of Pulmonary Medicine, Amsterdam UMC, VU University Medical Center, The Netherlands., Bosch LJW; Department of Pathology, Netherlands Cancer Institute, The Netherlands., Monkhorst K; Department of Pathology, Netherlands Cancer Institute, The Netherlands., Smit EF; Department of Thoracic Oncology, Netherlands Cancer Institute, The Netherlands; Department of Pulmonary Diseases, Leiden University Medical Center, The Netherlands., Boelens MC; Department of Pathology, Netherlands Cancer Institute, The Netherlands., de Langen AJ; Department of Thoracic Oncology, Netherlands Cancer Institute, The Netherlands. Electronic address: j.d.langen@nki.nl.
Publikováno v:
Lung cancer (Amsterdam, Netherlands) [Lung Cancer] 2024 Sep 28; Vol. 198, pp. 107972. Date of Electronic Publication: 2024 Sep 28.
Autor:
Hummelink K; Department of Pathology, Division of Diagnostic Oncology, the Netherlands Cancer Institute, Amsterdam, the Netherlands.; Department of Thoracic Oncology, Division of Medical Oncology, the Netherlands Cancer Institute, Amsterdam, the Netherlands., Tissier R; Biostatistics Unit, the Netherlands Cancer Institute, Amsterdam, the Netherlands., Bosch LJW; Department of Pathology, Division of Diagnostic Oncology, the Netherlands Cancer Institute, Amsterdam, the Netherlands., Krijgsman O; Division of Molecular Oncology and Immunology, the Netherlands Cancer Institute, Amsterdam, the Netherlands., van den Heuvel MM; Department of Thoracic Oncology, Division of Medical Oncology, the Netherlands Cancer Institute, Amsterdam, the Netherlands., Theelen WSME; Department of Thoracic Oncology, Division of Medical Oncology, the Netherlands Cancer Institute, Amsterdam, the Netherlands., Damotte D; Team Cancer, Immune Control and Escape, Cordeliers Research Center, UMRS 1138, Institut National de la Santé et de la Recherche Médicale (INSERM), Paris, France.; University Paris Cité, Paris, France.; CERTIM, Medical Oncology, Hôpital Cochin, APHP, Paris, France., Goldwasser F; University Paris Cité, Paris, France.; CERTIM, Medical Oncology, Hôpital Cochin, APHP, Paris, France., Leroy K; Team Cancer, Immune Control and Escape, Cordeliers Research Center, UMRS 1138, Institut National de la Santé et de la Recherche Médicale (INSERM), Paris, France.; University Paris Cité, Paris, France.; CERTIM, Medical Oncology, Hôpital Cochin, APHP, Paris, France.; Department of Biochemistry, Hôpital Cochin, Européen Georges Pompidou, APHP Centre, Paris, France., Smit EF; Department of Thoracic Oncology, Division of Medical Oncology, the Netherlands Cancer Institute, Amsterdam, the Netherlands., Meijer GA; Department of Pathology, Division of Diagnostic Oncology, the Netherlands Cancer Institute, Amsterdam, the Netherlands., Thommen DS; Division of Molecular Oncology and Immunology, the Netherlands Cancer Institute, Amsterdam, the Netherlands., Monkhorst K; Department of Pathology, Division of Diagnostic Oncology, the Netherlands Cancer Institute, Amsterdam, the Netherlands.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2024 Feb 16; Vol. 30 (4), pp. 814-823.
Autor:
Borghaei H; Hematology and Oncology Department, Fox Chase Cancer Center, Philadelphia, USA. Electronic address: Hossein.Borghaei@fccc.edu., de Marinis F; Division of Thoracic Oncology, European Institute of Oncology, IRCCS, Milan, Italy., Dumoulin D; Department of Pulmonary Medicine, Erasmus Medisch Centrum, Rotterdam, the Netherlands., Reynolds C; Ocala Cancer Center, Florida Cancer Specialists and Research Institute - North Region (SCRI), Ocala, USA., Theelen WSME; Department of Thoracic Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Percent I; North Port Cancer Center, Florida Cancer Specialists and Research Institute - South Region (SCRI), Port Charlotte, USA., Gutierrez Calderon V; Department of Medical Oncology, Hospital Regional Universitario de Málaga, Málaga, Spain., Johnson ML; Department of Medical Oncology, Sarah Cannon Research Institute, Tennessee Oncology, Nashville, USA., Madroszyk-Flandin A; Department of Medicine, Institut Paoli-Calmettes, Marseille, France., Garon EB; Division of Hematology-Oncology, David Geffen School of Medicine, University of California, Los Angeles., He K; Comprehensive Cancer Center, Pelotonia Institute for Immuno-Oncology, The Ohio State University, Columbus, USA., Planchard D; Department of Medical Oncology, Institut Gustave Roussy, Villejuif, France., Reck M; Department of Thoracic Oncology, LungenClinic, Airway Research Center North, German Center for Lung Research, Grosshansdorf, Germany., Popat S; Lung Unit, Department of Medicine, The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, London, UK., Herbst RS; Section of Medical Oncology, Yale University, New Haven., Leal TA; Department of Hematology and Medical Oncology, Winship Cancer Institute, Emory University, Atlanta., Shazer RL; Department of Clinical Research and Development, Mirati Therapeutics, Inc., San Diego, USA., Yan X; Department of Clinical Research and Development, Mirati Therapeutics, Inc., San Diego, USA., Harrigan R; Department of Clinical Research and Development, Mirati Therapeutics, Inc., San Diego, USA., Peters S; Department of Oncology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2024 Jan; Vol. 35 (1), pp. 66-76. Date of Electronic Publication: 2023 Oct 20.
Autor:
Blomberg OS; Division of Tumor Biology & Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands; Oncode Institute, Utrecht, the Netherlands; Department of Immunology, Leiden University Medical Centre, Leiden, the Netherlands., Spagnuolo L; Division of Tumor Biology & Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands; Oncode Institute, Utrecht, the Netherlands., Garner H; Division of Tumor Biology & Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands; Oncode Institute, Utrecht, the Netherlands., Voorwerk L; Division of Tumor Biology & Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Isaeva OI; Division of Tumor Biology & Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands; Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam, the Netherlands., van Dyk E; Division of Tumor Biology & Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands; Oncode Institute, Utrecht, the Netherlands; Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Bakker N; Division of Tumor Biology & Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands; Oncode Institute, Utrecht, the Netherlands., Chalabi M; Division of Molecular Oncology & Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands; Department of Gastrointestinal Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Klaver C; Division of Tumor Biology & Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Duijst M; Division of Tumor Biology & Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Kersten K; Division of Tumor Biology & Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Brüggemann M; Division of Tumor Biology & Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Pastoors D; Division of Tumor Biology & Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands; Oncode Institute, Utrecht, the Netherlands., Hau CS; Division of Tumor Biology & Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands; Oncode Institute, Utrecht, the Netherlands., Vrijland K; Division of Tumor Biology & Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands; Oncode Institute, Utrecht, the Netherlands., Raeven EAM; Division of Tumor Biology & Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands; Oncode Institute, Utrecht, the Netherlands., Kaldenbach D; Division of Tumor Biology & Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands; Oncode Institute, Utrecht, the Netherlands., Kos K; Division of Tumor Biology & Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands; Oncode Institute, Utrecht, the Netherlands; Department of Immunology, Leiden University Medical Centre, Leiden, the Netherlands., Afonina IS; VIB-UGent Center for Inflammation Research, Ghent University, Ghent, Belgium; Department of Biomedical Molecular Biology, Ghent University, Ghent, Belgium., Kaptein P; Division of Molecular Oncology & Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Hoes L; Oncode Institute, Utrecht, the Netherlands; Division of Molecular Oncology & Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Theelen WSME; Department of Thoracic Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Baas P; Department of Thoracic Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Voest EE; Oncode Institute, Utrecht, the Netherlands; Division of Molecular Oncology & Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Beyaert R; VIB-UGent Center for Inflammation Research, Ghent University, Ghent, Belgium; Department of Biomedical Molecular Biology, Ghent University, Ghent, Belgium., Thommen DS; Division of Molecular Oncology & Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands., Wessels LFA; Oncode Institute, Utrecht, the Netherlands; Division of Molecular Carcinogenesis, The Netherlands Cancer Institute, Amsterdam, the Netherlands., de Visser KE; Division of Tumor Biology & Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands; Oncode Institute, Utrecht, the Netherlands; Department of Immunology, Leiden University Medical Centre, Leiden, the Netherlands. Electronic address: k.d.visser@nki.nl., Kok M; Division of Tumor Biology & Immunology, The Netherlands Cancer Institute, Amsterdam, the Netherlands; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, the Netherlands. Electronic address: m.kok@nki.nl.
Publikováno v:
Cancer cell [Cancer Cell] 2023 Jan 09; Vol. 41 (1), pp. 106-123.e10. Date of Electronic Publication: 2022 Dec 15.
Autor:
Hummelink K; Department of Pathology, Division of Diagnostic Oncology, the Netherlands Cancer Institute, Amsterdam, the Netherlands.; Department of Thoracic Oncology, Division of Medical Oncology, the Netherlands Cancer Institute, Amsterdam, the Netherlands., van der Noort V; Department of Biometrics, the Netherlands Cancer Institute, Amsterdam, the Netherlands., Muller M; Department of Thoracic Oncology, Division of Medical Oncology, the Netherlands Cancer Institute, Amsterdam, the Netherlands., Schouten RD; Department of Thoracic Oncology, Division of Medical Oncology, the Netherlands Cancer Institute, Amsterdam, the Netherlands., Lalezari F; Department of Radiology, Division of Diagnostic Oncology, the Netherlands Cancer Institute, Amsterdam, the Netherlands., Peters D; Core Facility Molecular Pathology and Biobanking, Division of Molecular Pathology, the Netherlands Cancer Institute, Amsterdam, the Netherlands., Theelen WSME; Department of Thoracic Oncology, Division of Medical Oncology, the Netherlands Cancer Institute, Amsterdam, the Netherlands., Koelzer VH; Department of Pathology and Molecular Pathology, University Hospital Zurich, Zurich, Switzerland., Mertz KD; Institute of Pathology, Cantonal Hospital Baselland, Liestal, Switzerland., Zippelius A; Department of Biomedicine, University Hospital Basel, Basel, Switzerland., van den Heuvel MM; Department of Thoracic Oncology, Division of Medical Oncology, the Netherlands Cancer Institute, Amsterdam, the Netherlands., Broeks A; Core Facility Molecular Pathology and Biobanking, Division of Molecular Pathology, the Netherlands Cancer Institute, Amsterdam, the Netherlands., Haanen JBAG; Division of Molecular Oncology and Immunology, the Netherlands Cancer Institute, Amsterdam, the Netherlands., Schumacher TN; Division of Molecular Oncology and Immunology, the Netherlands Cancer Institute, Oncode Institute, Amsterdam, the Netherlands., Meijer GA; Department of Pathology, Division of Diagnostic Oncology, the Netherlands Cancer Institute, Amsterdam, the Netherlands., Smit EF; Department of Thoracic Oncology, Division of Medical Oncology, the Netherlands Cancer Institute, Amsterdam, the Netherlands., Monkhorst K; Department of Pathology, Division of Diagnostic Oncology, the Netherlands Cancer Institute, Amsterdam, the Netherlands., Thommen DS; Division of Molecular Oncology and Immunology, the Netherlands Cancer Institute, Amsterdam, the Netherlands.
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2022 Nov 14; Vol. 28 (22), pp. 4893-4906.
Autor:
van der Woude LL; Department of Tumour Immunology, Radboudumc, Nijmegen, The Netherlands.; Department of Pathology, Radboudumc, Nijmegen, The Netherlands.; Division of Immunotherapy, Oncode Institute, Radboudumc, Nijmegen, the Netherlands., Gorris MAJ; Department of Tumour Immunology, Radboudumc, Nijmegen, The Netherlands.; Division of Immunotherapy, Oncode Institute, Radboudumc, Nijmegen, the Netherlands., Wortel IMN; Data Science, Institute for Computing and Information Sciences, Radboud University, Nijmegen, the Netherlands., Creemers JHA; Department of Tumour Immunology, Radboudumc, Nijmegen, The Netherlands.; Division of Immunotherapy, Oncode Institute, Radboudumc, Nijmegen, the Netherlands., Verrijp K; Department of Tumour Immunology, Radboudumc, Nijmegen, The Netherlands.; Department of Pathology, Radboudumc, Nijmegen, The Netherlands.; Division of Immunotherapy, Oncode Institute, Radboudumc, Nijmegen, the Netherlands., Monkhorst K; Department of Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands., Grünberg K; Department of Pathology, Radboudumc, Nijmegen, The Netherlands., van den Heuvel MM; Department of Pulmonary Diseases, Radboudumc, Nijmegen, The Netherlands., Textor J; Department of Tumour Immunology, Radboudumc, Nijmegen, The Netherlands.; Data Science, Institute for Computing and Information Sciences, Radboud University, Nijmegen, the Netherlands., Figdor CG; Department of Tumour Immunology, Radboudumc, Nijmegen, The Netherlands., Piet B; Department of Pulmonary Diseases, Radboudumc, Nijmegen, The Netherlands., Theelen WSME; Department of Pulmonology, Netherlands Cancer Institute, Amsterdam, The Netherlands., de Vries IJM; Department of Tumour Immunology, Radboudumc, Nijmegen, The Netherlands jolanda.devries@radboudumc.nl.
Publikováno v:
Journal for immunotherapy of cancer [J Immunother Cancer] 2022 Oct; Vol. 10 (10).
Autor:
Theelen WSME; Department of Thoracic Oncology, The Netherlands Cancer Institute, Amsterdam, Netherlands., Chen D; Department of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical Sciences, Jinan, Shandong, China. Electronic address: chendawei0505@yahoo.com., Verma V; Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX, USA., Hobbs BP; Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH, USA., Peulen HMU; Department of Radiation Oncology, The Netherlands Cancer Institute, Amsterdam, Netherlands; Department of Radiation Oncology, Catharina Hospital, Eindhoven, Netherlands., Aerts JGJV; Department of Pulmonology, Erasmus Medical Center, Rotterdam, Netherlands., Bahce I; Department of Pulmonology, VU Medical Center, Amsterdam, Netherlands., Niemeijer ALN; Department of Pulmonology, VU Medical Center, Amsterdam, Netherlands., Chang JY; Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX, USA., de Groot PM; Department of Diagnostic Radiology, The University of Texas M D Anderson Cancer Center, Houston, TX, USA., Nguyen QN; Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX, USA., Comeaux NI; Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX, USA., Simon GR; Department of Thoracic/Head & Neck Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX, USA., Skoulidis F; Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX, USA., Lin SH; Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX, USA., He K; Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX, USA., Patel R; Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX, USA., Heymach J; Department of Thoracic/Head & Neck Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX, USA., Baas P; Department of Thoracic Oncology, The Netherlands Cancer Institute, Amsterdam, Netherlands., Welsh JW; Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston, TX, USA. Electronic address: jwelsh@mdanderson.org.
Publikováno v:
The Lancet. Respiratory medicine [Lancet Respir Med] 2021 May; Vol. 9 (5), pp. 467-475. Date of Electronic Publication: 2020 Oct 20.
Autor:
Hopstaken JS; Nederlands Kankerinstituut-Antoni van Leeuwenhoek, afd. Chirurgie, Amsterdam (thans: Radboudumc, afd. Chirurgie, Nijmegen)., de Ruiter JC; Nederlands Kankerinstituut-Antoni van Leeuwenhoek, afd. Chirurgie, Amsterdam., van Diessen JNA; Nederlands Kankerinstituut-Antoni van Leeuwenhoek, afd. Radiotherapie, Amsterdam., Theelen WSME; Nederlands Kankerinstituut-Antoni van Leeuwenhoek, afd. Thoracale Oncologie, Amsterdam., Monkhorst K; Nederlands Kankerinstituut-Antoni van Leeuwenhoek, afd. Pathologie, Amsterdam., Hartemink KJ; Nederlands Kankerinstituut-Antoni van Leeuwenhoek, afd. Chirurgie, Amsterdam.; Contact: K.J. Hartemink (k.hartemink@nki.nl).
Publikováno v:
Nederlands tijdschrift voor geneeskunde [Ned Tijdschr Geneeskd] 2021 Feb 04; Vol. 165. Date of Electronic Publication: 2021 Feb 04.
Autor:
Papadimitrakopoulou VA; Department of Thoracic Head and Neck Medical Oncology, The University of Texas, MD Anderson Cancer Center, Houston, USA., Mok TS; State Key Laboratory of Translational Oncology, Department of Clinical Oncology, Chinese University of Hong Kong, Hong Kong, People's Republic of China., Han JY; Center for Lung Cancer, National Cancer Center, Goyang, Republic of Korea., Ahn MJ; Department of Hematology and Oncology, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea., Delmonte A; Department of Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST), IRCCS, Meldola, Italy., Ramalingam SS; Department of Hematology and Medical Oncology, Emory University School of Medicine Winship Cancer Institute, Atlanta, USA., Kim SW; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea., Shepherd FA; Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Ontario, Canada; Department of Medical Oncology and Hematology, The University of Toronto, Ontario, Canada., Laskin J; Department of Medicine, BC Cancer Agency, Vancouver, British Columbia, Canada., He Y; Department of Respiratory Disease, Daping Hospital, Chongqing, People's Republic of China., Akamatsu H; Internal Medicine III, Wakayama Medical University Hospital, Wakayama, Japan., Theelen WSME; Department of Thoracic Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Su WC; Department of Oncology, National Cheng Kung University Hospital, Tainan, Taiwan., John T; Department of Medical Oncology, Olivia Newton-John Cancer Research Institute, Austin Health, Melbourne, Australia., Sebastian M; Department of Medicine, Hematology and Oncology, University Hospital Frankfurt, Frankfurt, Germany., Mann H; Oncology R&D, AstraZeneca, Cambridge, UK., Miranda M; Oncology R&D, AstraZeneca, Cambridge, UK., Laus G; Global Medicines Development, AstraZeneca, Cambridge, UK., Rukazenkov Y; Global Medicines Development, AstraZeneca, Cambridge, UK., Wu YL; Guangdong Lung Cancer Institute, Guangdong Provincial People's Hospital and Guangdong Academy of Medical Sciences, Guangzhou, People's Republic of China. Electronic address: syylwu@live.cn.
Publikováno v:
Annals of oncology : official journal of the European Society for Medical Oncology [Ann Oncol] 2020 Nov; Vol. 31 (11), pp. 1536-1544. Date of Electronic Publication: 2020 Aug 27.
Autor:
Theelen WSME; Department of Thoracic Oncology, The Netherlands Cancer Institute, Postbus 90203, 1006 BE, Amsterdam, The Netherlands. w.theelen@nki.nl., Krijgsman O; Division of Molecular Oncology & Immunology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Monkhorst K; Division of Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Kuilman T; Division of Molecular Oncology & Immunology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Neogene Therapeutics, Amsterdam, The Netherlands., Peters DDGC; Core Facility Molecular Pathology & Biobanking, Department of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Cornelissen S; Core Facility Molecular Pathology & Biobanking, Department of Molecular Pathology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Ligtenberg MA; Division of Molecular Oncology & Immunology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., Willems SM; Department of Pathology, University Medical Centre Groningen, Groningen, The Netherlands., Blaauwgeers JLG; Department of Pathology, OLVG LAB BV, Amsterdam, The Netherlands., van Noesel CJM; Department of Pathology, Academic Medical Center, Amsterdam, The Netherlands., Peeper DS; Division of Molecular Oncology & Immunology, The Netherlands Cancer Institute, Amsterdam, The Netherlands., van den Heuvel MM; Department of Pulmonology, Radboud University Medical Center, Nijmegen, The Netherlands., Schulze K; Oncology Biomarker Development, Genentech Inc, South San Francisco, USA.
Publikováno v:
Journal of translational medicine [J Transl Med] 2020 Jul 03; Vol. 18 (1), pp. 271. Date of Electronic Publication: 2020 Jul 03.